Amgen seeks U.S. approval of new cholesterol-fighting drug

[riky]

Amgen seeks U.S. approval of new cholesterol-fighting drug

(Reuters) - Amgen Inc said on Thursday it applied to U.S. Amgen is racing with Regeneron Inc to bring to market the potentially lucrative new drugs aimed at patients unable to tolerate widely used statins, and those who cannot sufficiently lower cholesterol despite use of statins, such as Pfizer Inc's Lipitor, or other medicines. The injectable drugs work by blocking a naturally occurring protein called PCSK9 that prevents the liver from removing LDL cholesterol, the "bad" cholesterol, from the bloodstream.

Source: You are not allowed to view links. Register or Login